Insulin aspart, recombinant Subcutaneous and Letermovir Intravenous
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Letermovir Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: letermovir
Brand name: Prevymis
Synonyms: Letermovir (oral/injection), Letermovir
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Letermovir oral/injection
- Insulin aspart, recombinant Subcutaneous-Letermovir Tablets
- Insulin aspart, recombinant Subcutaneous-Letrozole
- Insulin aspart, recombinant Subcutaneous-Letrozole and ribociclib
- Insulin aspart, recombinant Subcutaneous-Leucovorin
- Insulin aspart, recombinant Subcutaneous-Leucovorin Calcium
- Letermovir Intravenous-Insulin degludec
- Letermovir Intravenous-Insulin Degludec (U-100) Prefilled Pens
- Letermovir Intravenous-Insulin Degludec (U-100) Vials
- Letermovir Intravenous-Insulin Degludec (U-200) Prefilled Pens
- Letermovir Intravenous-Insulin degludec and liraglutide
- Letermovir Intravenous-Insulin degludec and liraglutide Subcutaneous